Therapeutic opportunities for antagonism of macrophage migration inhibitory factor

Author： Morand Eric F Leech Michelle Iskander Magdy N

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.8, 2003-08, pp. : 1189-1212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrophage migration inhibitory factor

By Lolis Elias Bucala Richard

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 153-164

Informa Healthcare

Access to resources Recommend Favorite

Macrophage Migration Inhibitory Factor and the Discovery of Tautomerase Inhibitors

Current Pharmaceutical Design, Vol. 8, Iss. 14, 2002-06 ,pp. : 1297-1317

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Macrophage Migration Inhibitory Factor in Critical Illness

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 14, 2014-12 ,pp. : 1116-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?

Current Medicinal Chemistry, Vol. 25, Iss. 5, 2018-02 ,pp. : 601-605

Bentham Science Publishers

Access to resources Recommend Favorite

Serum macrophage migration inhibitory factor is correlated with atrial fibrillation

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite